Literature DB >> 20444890

Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Roland Houben1, Masahiro Shuda, Rita Weinkam, David Schrama, Huichen Feng, Yuan Chang, Patrick S Moore, Jürgen C Becker.   

Abstract

Merkel cell carcinoma (MCC) is the most aggressive skin cancer. Recently, it was demonstrated that human Merkel cell polyomavirus (MCV) is clonally integrated in approximately 80% of MCC tumors. However, direct evidence for whether oncogenic viral proteins are needed for the maintenance of MCC cells is still missing. To address this question, we knocked down MCV T-antigen (TA) expression in MCV-positive MCC cell lines using three different short hairpin RNA (shRNA)-expressing vectors targeting exon 1 of the TAs. The MCC cell lines used include three newly generated MCV-infected cell lines and one MCV-negative cell line from MCC tumors. Notably, all MCV-positive MCC cell lines underwent growth arrest and/or cell death upon TA knockdown, whereas the proliferation of MCV-negative cell lines remained unaffected. Despite an increase in the number of annexin V-positive, 7-amino-actinomycin D (7-AAD)-negative cells upon TA knockdown, activation of caspases or changes in the expression and phosphorylation of Bcl-2 family members were not consistently detected after TA suppression. Our study provides the first direct experimental evidence that TA expression is necessary for the maintenance of MCV-positive MCC and that MCV is the infectious cause of MCV-positive MCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444890      PMCID: PMC2898224          DOI: 10.1128/JVI.02400-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.

Authors:  Jürgen C Becker; Roland Houben; Selma Ugurel; Uwe Trefzer; Claudia Pföhler; David Schrama
Journal:  J Invest Dermatol       Date:  2008-07-17       Impact factor: 8.551

2.  Integrated viral genomes can be lost from adenovirus type 12-induced hamster tumor cells in a clone-specific, multistep process with retention of the oncogenic phenotype.

Authors:  A Pfeffer; R Schubbert; G Orend; K Hilger-Eversheim; W Doerfler
Journal:  Virus Res       Date:  1999-01       Impact factor: 3.303

3.  Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.

Authors:  Xavier Sastre-Garau; Martine Peter; Marie-Françoise Avril; Hélène Laude; Jérôme Couturier; Flore Rozenberg; Anna Almeida; Françoise Boitier; Agnès Carlotti; Benoît Couturaud; Nicolas Dupin
Journal:  J Pathol       Date:  2009-05       Impact factor: 7.996

Review 4.  Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma.

Authors:  Mireille Van Gele; J Helen Leonard; Nadine Van Roy; Heidi Van Limbergen; Simon Van Belle; Veronique Cocquyt; Helen Salwen; Anne De Paepe; Frank Speleman
Journal:  Int J Cancer       Date:  2002-09-10       Impact factor: 7.396

5.  Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors.

Authors:  Kelly M Garneski; Ashley H Warcola; Qinghua Feng; Nancy B Kiviat; J Helen Leonard; Paul Nghiem
Journal:  J Invest Dermatol       Date:  2008-07-24       Impact factor: 8.551

6.  The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare.

Authors:  Katie Ridd; Siegrid Yu; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2008-07-24       Impact factor: 8.551

Review 7.  Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.

Authors:  Brian S Schaffhausen; Thomas M Roberts
Journal:  Virology       Date:  2008-11-20       Impact factor: 3.616

Review 8.  Merkel cell carcinoma.

Authors:  J C Becker; D Schrama; R Houben
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

9.  Ultrastructural proof of polyomavirus in Merkel cell carcinoma tumour cells and its absence in small cell carcinoma of the lung.

Authors:  Charlotte T A H Wetzels; Jolanda G M Hoefnagel; Judith M J E Bakkers; Henry B P M Dijkman; Willeke A M Blokx; Willem J G Melchers
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

10.  Seroepidemiology of human polyomaviruses.

Authors:  Jaime M Kean; Suchitra Rao; Michael Wang; Robert L Garcea
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

View more
  185 in total

1.  Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen.

Authors:  Stephanie K Demetriou; Katherine Ona-Vu; Erin M Sullivan; Tiffany K Dong; Shu-Wei Hsu; Dennis H Oh
Journal:  Int J Cancer       Date:  2012-05-29       Impact factor: 7.396

2.  Activation of PI3K signaling in Merkel cell carcinoma.

Authors:  Valentina Nardi; Youngchul Song; Juan A Santamaria-Barria; Arjola K Cosper; Quynh Lam; Anthony C Faber; Genevieve M Boland; Beow Y Yeap; Kristin Bergethon; Vanessa L Scialabba; Hensin Tsao; Jeffrey Settleman; David P Ryan; Darrell R Borger; Atul K Bhan; Mai P Hoang; Anthony J Iafrate; James C Cusack; Jeffrey A Engelman; Dora Dias-Santagata
Journal:  Clin Cancer Res       Date:  2012-01-18       Impact factor: 12.531

Review 3.  Merkel cell carcinoma: a virus-induced human cancer.

Authors:  Yuan Chang; Patrick S Moore
Journal:  Annu Rev Pathol       Date:  2011-09-13       Impact factor: 23.472

Review 4.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

Review 5.  Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.

Authors:  Aric Colunga; Thomas Pulliam; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

6.  Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression.

Authors:  Kathleen F Richards; Anna Guastafierro; Masahiro Shuda; Tuna Toptan; Patrick S Moore; Yuan Chang
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

7.  T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.

Authors:  Rikke Lyngaa; Natasja Wulff Pedersen; David Schrama; Charlotte Albæk Thrue; Dafina Ibrani; Ozcan Met; Per Thor Straten; Paul Nghiem; Jürgen C Becker; Sine Reker Hadrup
Journal:  Clin Cancer Res       Date:  2014-02-13       Impact factor: 12.531

8.  Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.

Authors:  Aude G Chapuis; Olga K Afanasiev; Jayasri G Iyer; Kelly G Paulson; Upendra Parvathaneni; Joo Ha Hwang; Ivy Lai; Ilana M Roberts; Heather L Sloan; Shailender Bhatia; Kendall C Shibuya; Ted Gooley; Cindy Desmarais; David M Koelle; Cassian Yee; Paul Nghiem
Journal:  Cancer Immunol Res       Date:  2014-01       Impact factor: 11.151

Review 9.  Merkel cell polyomavirus infection and Merkel cell carcinoma.

Authors:  Wei Liu; Margo MacDonald; Jianxin You
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

10.  Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer.

Authors:  Harri Sihto; Heikki Joensuu
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.